Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Pasmant

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Plos One|March 26, 2019
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomasGuillaume Beinse, Pierre-Alexandre Just, Bastien Rance, et al.
Neuro-Oncology|February 7, 2018
Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosisCamille Louvrier, Eric Pasmant, Audrey Briand-Suleau, et al.
Endocrine Pathology|August 24, 2024
Somatic Molecular Heterogeneity in Bilateral Macronodular Adrenocortical Disease (BMAD) Differs Among the Pathological SubgroupsFlorian Violon, Lucas Bouys, Patricia Vaduva, et al.
Non-Coding RNA|August 24, 2019
High Positive Correlations between <i>ANRIL</i> and <i>p16</i>-<i>CDKN2A</i>/<i>p15</i>-<i>CDKN2B</i>/<i>p14</i>-<i>ARF</i> Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an <i>ANRIL-ARF</i> Bidirectional PromoterKinan Drak Alsibai, Sophie Vacher, Didier Meseure, et al.
Journal of Human Genetics|January 30, 2015
NF1 single and multi-exons copy number variations in neurofibromatosis type 1Apolline Imbard, Eric Pasmant, Audrey Sabbagh, et al.
Acta Neuropathologica Communications|May 3, 2026
Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targetsAnaïs Brunet, Fanny Coulpier, Audrey Onfroy, et al.
Thyroid : Official Journal of the American Thyroid Association|February 16, 2022
Redifferentiating Effect of Larotrectinib in <i>NTRK</i>-Rearranged Advanced Radioactive-Iodine Refractory Thyroid CancerLionel Groussin, Hélène Theodon, Laura Bessiene, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2023
Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 DeletionsLaurence Pacot, Manuela Ye, Juliette Nectoux, et al.
Nature Communications|January 22, 2019
BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylationAntoine Campagne, Ming-Kang Lee, Dina Zielinski, et al.
BMC Genomics|July 16, 2013
MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesisJulien Masliah-Planchon, Eric Pasmant, Armelle Luscan, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Plos One|March 26, 2019
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomasGuillaume Beinse, Pierre-Alexandre Just, Bastien Rance, et al.
Neuro-Oncology|February 7, 2018
Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosisCamille Louvrier, Eric Pasmant, Audrey Briand-Suleau, et al.
Endocrine Pathology|August 24, 2024
Somatic Molecular Heterogeneity in Bilateral Macronodular Adrenocortical Disease (BMAD) Differs Among the Pathological SubgroupsFlorian Violon, Lucas Bouys, Patricia Vaduva, et al.
Non-Coding RNA|August 24, 2019
High Positive Correlations between <i>ANRIL</i> and <i>p16</i>-<i>CDKN2A</i>/<i>p15</i>-<i>CDKN2B</i>/<i>p14</i>-<i>ARF</i> Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an <i>ANRIL-ARF</i> Bidirectional PromoterKinan Drak Alsibai, Sophie Vacher, Didier Meseure, et al.
Journal of Human Genetics|January 30, 2015
NF1 single and multi-exons copy number variations in neurofibromatosis type 1Apolline Imbard, Eric Pasmant, Audrey Sabbagh, et al.
Acta Neuropathologica Communications|May 3, 2026
Immune landscape characterization of neurofibromas with atypical features in Neurofibromatosis1 reveals PD-1 and the Tim-3/Galectin-9 pathway as potential therapeutic targetsAnaïs Brunet, Fanny Coulpier, Audrey Onfroy, et al.
Thyroid : Official Journal of the American Thyroid Association|February 16, 2022
Redifferentiating Effect of Larotrectinib in <i>NTRK</i>-Rearranged Advanced Radioactive-Iodine Refractory Thyroid CancerLionel Groussin, Hélène Theodon, Laura Bessiene, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2023
Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 DeletionsLaurence Pacot, Manuela Ye, Juliette Nectoux, et al.
Nature Communications|January 22, 2019
BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylationAntoine Campagne, Ming-Kang Lee, Dina Zielinski, et al.
BMC Genomics|July 16, 2013
MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesisJulien Masliah-Planchon, Eric Pasmant, Armelle Luscan, et al.
Pageof 13